4 results found.

Acute Lymphoblastic Leukemia Clinical Trial using VDCLD regimen

Changzhou Jinyuan Pharmaceutical Manufacturing Co., Ltd. - Recruiting 14 years to 60 years.
- Pegylated Liposomal Doxorubicin-contained Versus Daunorubicin-contained VDCLD Regimen in Previously Untreated Adult Patients With Acute Lymphoblastic Leukemia: Complete Remission Rates and Changes of Leukemia Stem Cells.
VDCLD regimen

B-cell Childhood Acute Lymphoblastic Leukemia, Philadelphia Chrom Clinical Trial using doxorubicin hydrochloride; cytarabine; vincristine sulfate; dexamethasone; pegaspargase; methotrexate; mercaptopurine tablet; leucovorin calcium; cyclophosphamide; thioguanine; quality-of-life assessment; questionnaire administration; laboratory biomarker analysis

Children's Oncology Group - Recruiting 1 year to 30 years.
- Treatment of Patients With Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL).
doxorubicin hydrochloride; cytarabine; vincristine sulfate; dexamethasone; pegaspargase; methotrexate; mercaptopurine tablet; leucovorin calcium; cyclophosphamide; thioguanine; quality-of-life assessment; questionnaire administration; laboratory biomarker analysis

Untreated Adult Acute Lymphoblastic Leukemia, or Untreated Childh Clinical Trial using laboratory biomarker analysis

Children's Oncology Group - Recruiting N/A to 30 years.
- Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL).
laboratory biomarker analysis

B-cell Adult Acute Lymphoblastic Leukemia, Philadelphia Chromosom Clinical Trial using cytarabine; daunorubicin hydrochloride; vincristine sulfate; dexamethasone; methotrexate; pegaspargase; cyclophosphamide; mercaptopurine tablet; blinatumomab; etoposide; prednisone; allogeneic hematopoietic stem cell transplantation; laboratory biomarker analysis

National Cancer Institute (NCI) - Recruiting 35 years to 70 years.
- A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in Adults.
cytarabine; daunorubicin hydrochloride; vincristine sulfate; dexamethasone; methotrexate; pegaspargase; cyclophosphamide; mercaptopurine tablet; blinatumomab; etoposide; prednisone; allogeneic hematopoietic stem cell transplantation; laboratory biomarker analysis